Business
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
Hi, what are you looking for?
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
– Glass Lewis even recommends against board motions to which Benny Landa has not objected. A day after ISS recommended investors to support Teva...
– The German company has taken a minority stake in Benny Landa’snanographi c printing venture. – – German specialty chemicals group Altana is investing $135...
– The activist shareholder still fears that the Teva board won’t do what the company needs. – – “These are definitely steps in the...
– Chaim Hurvitz and Dan Suesskind will step down and Chairman Phillip Frost will leave before the end of the year. – – Chaim...
– Eyal Desheh: There are many small US companies developing complex generic products. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is eying small acquisitions...
– The price is high because Teva considers Cipla an ideal fit. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has made a $6 billion...
– Sources: Starbucks is seeking 10% of SodaStream at a company value of $1.1 billion – a 30% premium on the market price. –...
– The return on Sagi’s investment in the Bezeq parent company was nearly 50%. – – Less than nine months after investing in B...
– The company does not admit to charges of paying a psychiatrist to prescribe Clozapine. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) does not admit that...